BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23331301)

  • 1. Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration.
    Llorens J
    J Intern Med; 2013 May; 273(5):478-89. PubMed ID: 23331301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of neurofilaments in the neuromuscular junction in a rat model of proximal axonopathy.
    Soler-Martín C; Vilardosa U; Saldaña-Ruíz S; Garcia N; Llorens J
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):61-71. PubMed ID: 21450050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of proximal neurofilamentous giant axonal swellings: implications for the pathogenesis of amyotrophic lateral sclerosis.
    Gold BG
    Toxicology; 1987 Oct; 46(2):125-39. PubMed ID: 3313811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor unit function during evolution of proximal axonal swellings.
    Delio DA; Fiori MG; Lowndes HE
    J Neurol Sci; 1992 May; 109(1):30-40. PubMed ID: 1381410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
    Graham DG; Anthony DC; Szakál-Quin G; Gottfried MR; Boekelheide K
    Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distal effects in a model of proximal axonopathy: 3,3'-iminodipropionitrile causes specific loss of neurofilaments in rat vestibular afferent endings.
    Seoane A; Demêmes D; Llorens J
    Acta Neuropathol; 2003 Nov; 106(5):458-70. PubMed ID: 12898157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper.
    LoPachin RM; Lehning EJ
    Neurotoxicology; 1997; 18(1):7-22. PubMed ID: 9215980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
    Collard JF; Côté F; Julien JP
    Nature; 1995 May; 375(6526):61-4. PubMed ID: 7536898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the NF-H gene increases axonal microtubule content and velocity of neurofilament transport: relief of axonopathy resulting from the toxin beta,beta'-iminodipropionitrile.
    Zhu Q; Lindenbaum M; Levavasseur F; Jacomy H; Julien JP
    J Cell Biol; 1998 Oct; 143(1):183-93. PubMed ID: 9763430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology.
    King AE; Dickson TC; Blizzard CA; Woodhouse A; Foster SS; Chung RS; Vickers JC
    Neurobiol Aging; 2011 Mar; 32(3):459-69. PubMed ID: 19427060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurotoxic substances as a tool to understand some mechanisms of peripheral neuropathies (author's transl)].
    Sebille A; Hugelin A
    Pathol Biol (Paris); 1982 Jan; 30(1):37-41. PubMed ID: 6174920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicants and the cytoskeleton.
    Graham DG
    Curr Opin Neurol; 1999 Dec; 12(6):733-7. PubMed ID: 10676757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. II. The effects of single doses of neurotoxic and non-neurotoxic diketones and beta, beta'-iminodipropionitrile (IDPN) on the rate and capacity of transport.
    Sickles DW
    Neurotoxicology; 1989; 10(1):103-11. PubMed ID: 2475834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon disulfide axonopathy. Another experimental model characterized by acceleration of neurofilament transport and distinct changes of axonal size.
    Pappolla M; Penton R; Weiss HS; Miller CH; Sahenk Z; Autilio-Gambetti L; Gambetti P
    Brain Res; 1987 Oct; 424(2):272-80. PubMed ID: 2445451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
    King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
    Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of experimental giant neurofilamentous axonopathies: a unified hypothesis based on chemical modification of neurofilaments.
    Sayre LM; Autilio-Gambetti L; Gambetti P
    Brain Res; 1985 Sep; 357(1):69-83. PubMed ID: 2412663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of two axonopathies does not require axonal neurofilaments.
    Eyer J; Cleveland DW; Wong PC; Peterson AC
    Nature; 1998 Feb; 391(6667):584-7. PubMed ID: 9468135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic proximal axonopathy in rats is associated with long-standing neurofilament depletion in neuromuscular junctions and behavioral deficits.
    Soler-Martín C; Boadas-Vaello P; Verdú E; Garcia N; Llorens J
    J Neuropathol Exp Neurol; 2014 Jun; 73(6):568-79. PubMed ID: 24806304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings.
    Anthony DC; Boekelheide K; Graham DG
    Toxicol Appl Pharmacol; 1983 Dec; 71(3):362-71. PubMed ID: 6686353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic axonal degeneration occurs independent of neurofilament accumulation.
    Sickles DW; Pearson JK; Beall A; Testino A
    J Neurosci Res; 1994 Oct; 39(3):347-54. PubMed ID: 7869427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.